Yeungnam Univ J Med.  2018 Jun;35(1):17-26. 10.12701/yujm.2018.35.1.17.

Recent updates in transcatheter aortic valve implantation

Affiliations
  • 1Division of Cardiology, Daegu Veterans Hospital, Daegu, Korea.
  • 2Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center, Daegu, Korea. woongwa@yu.ac.kr

Abstract

Transcatheter aortic valve implantation (TAVI) has evolved from a challenging intervention to a standardized, simple, and streamlined procedure with over 350,000 procedures performed in over 70 countries. It is now a novel alternative to surgical aortic valve replacement in patients with intermediate surgical risk and its indications have been expanded to cohorts with bicuspid aortic valves, low surgical risk, and younger age and fewer comorbidities. Attention should be paid to further reducing remaining complications, such as paravalvular aortic regurgitation, conduction abnormalities, cardiac tamponade, and stroke. The aim of this review is to provide an overview on the rapidly changing field of TAVI treatment and to explore past achievements, current issues, and future perspectives of this treatment modality.

Keyword

Aortic valve stenosis; Transcatheter aortic valve implantation; Surgery; Indications

MeSH Terms

Aortic Valve
Aortic Valve Insufficiency
Aortic Valve Stenosis
Bicuspid
Cardiac Tamponade
Cohort Studies
Comorbidity
Humans
Stroke
Transcatheter Aortic Valve Replacement*
Full Text Links
  • YUJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error